For Alzheimer's patients, a new era of treatment brings hope

A drug called Leqembi, which modestly slows progression of the disease, is expected soon to receive full approval from federal regulators.

Related Keywords

University Of The Pacific , California , United States , Kansas , Tokyo , Japan , Fayetteville , North Carolina , Stockton , Colorado Springs , Colorado , Cambridge , Cambridgeshire , United Kingdom , Duke University , University Of Kansas , Boston , Massachusetts , Americans , Howard Fillit , Eli Lilly , Allan Levey , Jay Reinstein , Mel Brooks , Reisa Sperling , R Scott Turner , Thomasm Wisniewski , Jeffreym Burns , Davids Knopman , Gil Rabinovici , Kenneth Covinsky , Larry David , Lois Reinstein , Drug Administration , Aetna , University Of Kansas Is Steve Grant , Alzheimer Drug Discovery Foundation , Langone Health , Emory University School Of Medicine , Centers For Disease , University Of California At San Francisco , Medstar Georgetown University Hospital , Alzheimer Association , Georgetown University School Of Medicine , Medstar Georgetown University , Emory University School , Mayo Clinic , Steve Grant , Joanna Fix , Drug Discovery Foundation , African Americans , Georgetown University School , Social Security , Medicare Advantage , Disease Control , Memory Disorders Clinic , Duke University Health Systems , Ella Fitzgerald , Cindy Beam ,